EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors

Xuelan Ma, Zhifeng Wen, Zhiwen Wang, Zhiqi Peng, Dongbo Wu, Jun Wang, Bo Liu

Acta Pharmaceutica Sinica B · 2026-07 · 16 (7) · 4196-4232

DOI: 10.1016/j.apsb.2026.03.047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-07. Verfasst von Xuelan Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan Universit…. Die Arbeit nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan University, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Atypical protein kinaseCancer hallmarkEukaryotic protein kinasesKinase inhibitorTargeted therapy

Autor:innen und Institutionen

  • Center of Infectious Diseases, Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Institute of Precision Drug Innovation and Cancer Center, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
  • Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China.

Förderung

  • National Natural Science Foundation of China
  • Sichuan University
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Ma, X., Wen, Z., Wang, Z., Peng, Z., Wu, D., Wang, J., & Liu, B. (2026). Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors. Acta Pharmaceutica Sinica B, 16(7), 4196-4232. https://doi.org/10.1016/j.apsb.2026.03.047

Vancouver

Ma X, Wen Z, Wang Z, Peng Z, Wu D, Wang J, et al. Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors. Acta Pharmaceutica Sinica B. 2026;16(7):4196-4232. doi:10.1016/j.apsb.2026.03.047

BibTeX
@article{Ma2026,
  author = {Ma, Xuelan and Wen, Zhifeng and Wang, Zhiwen and Peng, Zhiqi and Wu, Dongbo and Wang, Jun and Liu, Bo},
  title = {Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {4196--4232},
  doi = {10.1016/j.apsb.2026.03.047}
}
Kostenlos starten →